Year archive

ANAGENICS LIMITED — 2013 filings

All 64 regulatory filings released by ANAGENICS LIMITED (AN1) in 2013, sourced directly from the official regulator.

64 Filings

2013 Period

2013 filings (64)

Filing	Released	Lang
Cleansing Notice and Appendix 3B 10 pages 225.4KB Regulatory Filings	2013-12-19	English
Results of Completed CK3000 Diagnostic Study 3 pages 33.7KB Regulatory Filings	2013-12-17	English
Capital Raising of $2 million 1 page 48.4KB Regulatory Filings	2013-12-10	English
Trading Halt 2 pages 55.1KB Regulatory Filings	2013-12-08	English
Appendix 3B and Change of Interests of Substantial Holder 19 pages 1.3MB Regulatory Filings	2013-11-24	English
Cleansing Statement 2 pages 21.7KB Regulatory Filings	2013-11-24	English
Change of Director's Interest Notice - Maria Halasz 3 pages 77.3KB Regulatory Filings	2013-11-24	English
AGM PRESENTATION BY CEO 21 pages 1.2MB Regulatory Filings	2013-11-21	English
Results of Meeting 4 pages 81.0KB Regulatory Filings	2013-11-21	English
Change in substantial holding 10 pages 143.9KB Regulatory Filings	2013-11-19	English
Proposed Issue of Shares 1 page 22.4KB Regulatory Filings	2013-11-17	English
Release of Shares from Voluntary Escrow 1 page 22.8 Regulatory Filings	2013-10-29	English
Appendix 4C - quarterly 6 pages 94.6KB Regulatory Filings	2013-10-22	English
Cellmid News 8 pages 724.9KB Regulatory Filings	2013-10-22	English
Annual Report 79 pages 3.3MB Regulatory Filings	2013-10-20	English
Notice of Annual General Meeting and Proxy Form 28 pages 152.9KB Regulatory Filings	2013-10-20	English
Key Antibody Patent Granted in Japan 2 pages 325.5KB Regulatory Filings	2013-10-17	English
Key European Patent for Anti-Midkine Antibodies Granted 2 pages 30.1KB Regulatory Filings	2013-10-07	English
R&D Tax Refund Received 1 page 22.9KB Regulatory Filings	2013-10-03	English
Midkine antibodies effective in cancer 2 pages 30.4KB Regulatory Filings	2013-10-02	English
Ceasing to be a substantial holder 2 pages 35.6KB Regulatory Filings	2013-09-26	English
Cellmid Signs Major Japanese Distribution Agreement 2 pages 24.9KB Regulatory Filings	2013-09-19	English
Independent Valuation Report of Advangen Inc. Japan 20 pages 682.1KB Regulatory Filings	2013-09-18	English
Cellmid CEO Presents at Brokers Meets Biotech 25 pages 1.4MB Regulatory Filings	2013-09-17	English
Date of Annual General Meeting 1 page 20.6KB Regulatory Filings	2013-09-09	English
Change in substantial holding 10 pages 146.2KB Regulatory Filings	2013-09-02	English
Appendix 4E and Preliminary Final Report 64 pages 665.1KB Regulatory Filings	2013-08-27	English
Cellmid Received Pacific Edge Milestone Shares 2 pages 30.7KB Regulatory Filings	2013-07-31	English
Cellmid Collaborates on Early Diagnosis of Colorectal Cancer 2 pages 31.2KB Regulatory Filings	2013-07-28	English
Appendix 4C - quarterly 6 pages 98.0KB Regulatory Filings	2013-07-25	English
Release of Shares from Voluntary Escrow 1 page 18.9 Regulatory Filings	2013-07-21	English
Fujikura Exercises Option To License Cellmid Diagnostics 2 pages 30.9KB Regulatory Filings	2013-07-17	English
Appointment of Company Secretary 1 page 20.5KB Regulatory Filings	2013-07-15	English
Change of Director's Interest Notice 3 pages 75.8KB Regulatory Filings	2013-07-03	English
Change of Director's Interest Notice 4 pages 91.2KB Regulatory Filings	2013-06-11	English
Settlement of Advangen Inc. Acquisiton Completed - Form 603 12 pages 85.6KB Regulatory Filings	2013-05-27	English
Cellmid Newsletter 8 pages 807.4KB Regulatory Filings	2013-05-19	English
Appendix 3B 10 pages 229.8KB Regulatory Filings	2013-05-16	English
Advangen Acquisition 4 pages 35.8KB Regulatory Filings	2013-05-07	English
CEO Presentation 17 pages 914.9KB Regulatory Filings	2013-05-07	English
Trading Halt 2 pages 61.5KB Regulatory Filings	2013-05-05	English
Change of Company Address 1 page 20.8KB Regulatory Filings	2013-04-29	English
Appendix 4C - quarterly 6 pages 99.7KB Regulatory Filings	2013-04-21	English
Resignation of Company Secretary 1 page 20.9KB Regulatory Filings	2013-04-07	English
Change of Director's Interest Notice 2 pages 22.6KB Regulatory Filings	2013-04-02	English
Cellmid Diagnostic Licenses Update 3 pages 34.4KB Regulatory Filings	2013-03-25	English
Appendix 3B 9 pages 219.8KB Regulatory Filings	2013-03-21	English
Cellmid Completes $2M Placement 2 pages 26.3KB Regulatory Filings	2013-03-12	English
Cleansing Statement 2 pages 33.6KB Regulatory Filings	2013-03-12	English
Trading Halt 2 pages 61.4KB Regulatory Filings	2013-03-10	English
Response to ASX Price Query 3 pages 173.8KB Regulatory Filings	2013-03-07	English
Change of Director's Interest Notice - M Halasz 2 pages 22.6KB Regulatory Filings	2013-03-03	English
Response to ASX Price Query 3 pages 172.8KB Regulatory Filings	2013-02-26	English
Change of Director's Interest Notice - Martin Rogers 3 pages 17.1KB Regulatory Filings	2013-02-18	English
Appendix 4D and Half Year Accounts 19 pages 199.4KB Regulatory Filings	2013-02-14	English
Cellmid Signs Midkine Diagnostic Agreement 2 pages 30.2KB Regulatory Filings	2013-02-10	English
Appendix 4C - quarterly 6 pages 99.8KB Regulatory Filings	2013-01-28	English
Cellmid News 8 pages 1.1MB Regulatory Filings	2013-01-28	English
Positive Data in Midkine Antibody Study in Kidney Disease 3 pages 131.7KB Regulatory Filings	2013-01-22	English
Response to ASX Aware Query 5 pages 188.2KB Regulatory Filings	2013-01-21	English
EU Patent Allowed for Treating Vascular Occlusive Disease 2 pages 30.2KB Regulatory Filings	2013-01-20	English
Response to ASX Query - Diversity 5 pages 114.1KB Regulatory Filings	2013-01-14	English
Appendix 3Y - M Halasz 2 pages 19.1KB Regulatory Filings	2013-01-10	English
App 3Y - M Halasz 2 pages 19.3KB Regulatory Filings	2013-01-06	English

Filings by year

2026 22 filings
2025 55 filings
2024 51 filings
2023 49 filings
2022 34 filings
2021 2 filings
2020 80 filings
2019 53 filings
2018 66 filings
2017 59 filings
2016 62 filings
2015 56 filings
2014 36 filings
2013 64 filings
2012 73 filings
2011 51 filings
2010 31 filings
2009 11 filings
2008 66 filings
2007 55 filings
2006 72 filings
2005 19 filings